Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Eli Lilly and Company
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Randomized, Double-Blind, Cross-Over Study Comparing the Pharmacodynamic Response in Subjects with Acute Coronary Syndrome Receiving 14 Days 10-mg Maintenance Dose Prasugrel (LY640315) versus 14 Days 150-mg Maintenance Dose Clopidogrel After Using a 900-mg Loading Dose of Clopidogrel to Reduce Ongoing Platelet Activation – The ACAPULCO Study
to establish superiority of a prasugrel 10-mg daily maintenance dose compared with a clopidogrel 150-mg daily maintenance dose
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A study for patients with Type 2 Diabetes currently taking insulin glargine with or without metformin
The primary objective of this study is to show superiority of the addition of once weekly dulaglutide 1.5 mg compared to the addition of once weekly placebo to titrated basal insulin glargine, with or...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company, Indianapolis
MAJ Il y a 5 ans
A 12-Week, Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients with Type 2 Diabetes Mellitus
The primary objective of this study is to test the hypothesis that once-weekly injections of LY2428757 given to patients with T2DM inadequately controlled with diet and exercise alone, or metformin mo...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Phase 3 Study in Moderate to Severe Psoriasis Patients Közepesen súlyos vagy súlyos plakkos pszoriázisban szenvedő betegeken végzett 3-as fázisú klinikai vizsgálat
Efficacy of ixekizumab vs. etanercept and placebo in subjects with moderate to severe chronic plaque psoriasis based on sPGA and PASI at week 12
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
To evaluate the efficacy, in terms of Progression Free Survival (PFS), in patients with metastatic breast cancer for: •Abemaciclib 150 mg Q12H plus tamoxifen •Abemaciclib 150 mg Q12H •Abemacicli...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Study of LY2835219 in Participants With Previously Treated Lung Cancer
The co-primary objectives of this study are to compare LY2835219 plus BSC versus erlotinib plus BSC with respect to: • progression-free survival (PFS) • overall survival (OS)
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses versus Placebo in Patients with Type 2 Diabetes on Metformin Monotherapy
To show superiority of the 3 dulaglutide doses, including the two higher doses (4.5 mg and 3.0 mg) and the approved 1.5 mg dose to placebo in change in HbA1c.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Study of Ixekizumab in Patients with Axial Spondyloarthritis who have Previously Taken Tumor Necrosis Factor Inhibitors for Their Condition
Compare both ixekizumab regimens (80 mg every 2 weeks or 80 mg every 4 weeks) vs placebo in tumor necrosis factor inhibitor (TNFi) experienced patients with active radiographic axial spondyloarthritis...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Study of Ixekizumab in Participants With Active Psoriatic Arthritis Estudio de Ixekizumab en pacientes con artritis psoriásica activa
Efficacy of ixekizumab (LY2439821) compared to placebo in participants with active psoriatic arthritis who are biologic disease-modifying antirheumatic drugs (bDMARD0-experienced, as measured by the p...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
Eli Lilly and Company
MAJ Il y a 5 ans
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
The primary objective of this study is to test the hypothesis that the glycemic control achieved with preprandial HIIP is noninferior to that achieved with injectable insulin, as measured by mean chan...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Précédent
16
17
18
19
20
21
22
23
24
25
Suivant